Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
22627
Description
Maintaining Bone Strength in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00391950
Lien
https://clinicaltrials.gov/show/NCT00391950
Mots-clés
Versions (2)
- 08/06/2017 08/06/2017 -
- 02/09/2021 02/09/2021 -
Téléchargé le
8 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Cancer NCT00391950
Eligibility Prostate Cancer NCT00391950
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00391950
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Prostate carcinoma
Item
histologically confirmed diagnosis of carcinoma of the prostate
boolean
C0600139 (UMLS CUI [1])
Distant metastasis Absent
Item
no distant metastases
boolean
C1269798 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Indication Antiandrogen therapy
Item
patients must be candidates for androgen deprivation therapy (adt)
boolean
C3146298 (UMLS CUI [1,1])
C0279492 (UMLS CUI [1,2])
C0279492 (UMLS CUI [1,2])
Bone Mineral Density Test Lumbar spine T score
Item
patient with a baseline bmd t-score at or below -1 standard deviations in the lumbar spine (l2-l4) are eligible
boolean
C0177804 (UMLS CUI [1,1])
C3887615 (UMLS CUI [1,2])
C3854607 (UMLS CUI [1,3])
C3887615 (UMLS CUI [1,2])
C3854607 (UMLS CUI [1,3])
Bone Mineral Density Normal
Item
patients with normal bmd at trial entry
boolean
C0005938 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,2])
Diphosphonates
Item
patients who received any prior bisphosphonate therapy in the past 12 months
boolean
C0012544 (UMLS CUI [1])
Antiandrogen therapy | Antiandrogen therapy Combined
Item
treatment with anti-androgen mono- or combination therapy
boolean
C0279492 (UMLS CUI [1])
C0279492 (UMLS CUI [2,1])
C0009429 (UMLS CUI [2,2])
C0279492 (UMLS CUI [2,1])
C0009429 (UMLS CUI [2,2])
Diethylstilbestrol | PC-SPES
Item
patients who are currently receiving diethylstilbesterol (des) or who have previously received pc-spes
boolean
C0012203 (UMLS CUI [1])
C0756934 (UMLS CUI [2])
C0756934 (UMLS CUI [2])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
patients who have received prior treatment with systemic corticosteroids within the past 12 months
boolean
C3653708 (UMLS CUI [1])
Anabolic steroids Exposure to | Growth Hormone Exposure to
Item
patients with prior exposure to anabolic steroids or growth hormone within the past 6 months
boolean
C0002744 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
C0037663 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0332157 (UMLS CUI [1,2])
C0037663 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Therapeutic procedure Osteoporosis
Item
patients with any prior treatment for osteoporosis
boolean
C0087111 (UMLS CUI [1,1])
C0029456 (UMLS CUI [1,2])
C0029456 (UMLS CUI [1,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])